Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.

Abstract

BACKGROUND The effect of dimethyl fumarate (DMF) on circulating lymphocyte subsets and their contribution as predictors of clinical efficacy have not yet been investigated in multiple sclerosis (MS). OBJECTIVE To evaluate lymphocytes and lymphocyte subsets (analyzed 6 months after DMF start) in MS patients with and without disease activity after 1 year of… (More)
DOI: 10.1177/1352458517703799

Topics

Cite this paper

@article{Fleischer2017TreatmentRT, title={Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.}, author={Vinzenz Fleischer and Michaela Elena Friedrich and Ayman A. Rezk and Ulrike B{\"u}hler and Esther J. Witsch and T Uphaus and Stefan Bittner and Sergiu Groppa and Bjoern Tackenberg and Amit Bar-Or and Frauke Zipp and Felix Luessi}, journal={Multiple sclerosis}, year={2017}, pages={1352458517703799} }